Mechanism of Venous Pooling in POTS >>
Oxidative Streees in Autonomic Neurodegeneration >>
Plasma Normetanephrine in Pheochromocytoma >>
Pressor Effect of Water a Spinal Reflex? >>
Autonomic Failure in Parkinson's Disease >>
Role of Sympathetic Function in Hypertension >>
A PDF version of this Autonomic News can be downloaded from the CAR website
To review the original abstract of these articles, click on the references below
"Venous Pooling" Due to Interstitial Edema in
a Subset of Patients with POTS
I has been recognized clinically that patients with
POTS have exaggerated "venous pooling" on standing. However, few studies have
systematically studied whether this occurs in all patients, its mechanism, or
its potential importance in the pathophysiology of this disorder. Stewart has
previously reported that adolescents with POTS can be subset based on their
normal or inappropriately increased leg blood flow while upright. Now he reports
that patients who have high leg blood flow and impaired vasoconstriction also
have increased microvascular filtration in lower limbs, as suggested previously
by Brown and Hainsworth (Clin Auton Res 1999;9:69-73). In contrast, patients
with normal orthostatic leg blood flow seem to have normal microvascular
filtration.
This work provides a mechanism for the "venous pooling"
observed clinically, and adds to the evidence that orthostatic intolerance is a
heterogeneous disease. Stewart's subset of patients with inappropriately high
orthostatic leg blood flow may correspond to the neuropathic (lower limb
denervation) form of the disease.
Stewart JM (2003) Microvascular filtration is increased in
postural tachycardia syndrome. Circulation 107:2816-2822.
Markers of Oxidative Stress in
Parkinson Disease and Related Disorders
Oxidative stress has been suspected as contributing to
neurodegenerative disorders, including Parkinson’s disease and related
conditions. Fessel et al measured products of lipid oxidation in post-mortem
substantial nigra samples of controls (n=5), patients with Parkinson’s disease
(PD, 7), multiple system atrophy (MSA, 4), dementia of Lewy body disease (DLB,
4) and Alzheimer’s disease (AD, 5). They measured F2-isoprostanes and isofurans.
Both are products of lipid peroxidation, but formation of isofurans is favored
under conditions of increased oxygen tension. Isofurans were increased only in
PD and DLB, but not in MSA or AD. F2-isoprostanes were slightly higher in PD and
DLB, but differences were not significant. The authors conclude that high oxygen
tension oxidative stress contributes to Parkinson’s disease and Lewy body
disease, but not to multiple system atrophy. These findings, if confirmed in a
larger number of specimens, would suggest different underlying mechanisms of
dopaminergic neurogeneration between these conditions.
Fessel JP, Hulette C, Powell S, et al (2003) Isofurans, but not
F2-isoprostanes, are increased in the substantia nigra of patients with
Parkinson's disease and with dementia with Lewy body disease. J Neurochem
85:645-650.
Plasma Normetanephrine in the
Biochemical Diagnosis of Pheochromocytoma
Diagnosis of pheochromocytoma remains a
challenge. Eisenhofer et al examined the biochemical characteristics of 208
patient with pathologically-confirmed pheochromocytoma and 648 in whom
pheochromocytoma was excluded. Plasma norepinephrine > 2,400,
normetanephrine > 400 and metanephrine > 235 pg/ml where highly suggestive of
pheochromocytoma. Plasma catechols were between normal and these high values in
a substantial number of patients with (true positives) and without (false
positives) pheochromocytoma. False positives can be resolved with the clonidine
suppression test. Suppression of normetanephrine was found to be more
reliable than that of norepinephrine. False positive elevations of plasma
catechols were frequently caused by tricyclic antidepressants (but not by
selective serotonin reuptake inhibitors) and the alpha blocker phenoxybenzamine
(frequently used to treat pheochromocytoma). Some patients with pheochromocytoma
had normal plasma normetanephrine. The incidence of this problem may be enriched
in this series because of the inclusion of asymptomatic patients that were
screened because of familiar pheochromocytoma.
Eisenhofer G, Goldstein DS, Walther MM, et al (2003) Biochemical diagnosis
of pheochromocytoma: How to distinguish true- from false-positive test results.
Journal of Clinical Endocrinology and Metabolism 88:2656-2666.
Is the Pressor Effect of Water a Spinal
Reflex?
Plain, room-temperature, tap water can increase systolic
blood pressure by an average of 40 mm Hg in autonomic failure patients.
Sympathetic mechanisms appear to be involved because this effect is prevented by
autonomic blockade with trimethaphan. Tank et al now report that water also
increases blood pressure in tetraplegic patients with complete spinal cord
injury. Mean systolic blood pressure increased from 123 to 138 mm Hg after 35-40
min. This was associated with reflex bradycardia and increased total peripheral
resistance. Thus, the pressor effect of water is seen even if the direct
connection between CNS centers and efferent sympathetic nerve fibers is
interrupted. It is unlikely that oral water increases blood pressure by
increasing volume, because previous studies have shown that the same volume
infused intravenously has no pressor effect, sympathetic activation has been
documented in normals, and vasoconstriction was observed in this study. These
results suggest that a spinal reflex is involved in the genesis of the pressor
effect of water. We still don’t know the afferent signal that triggers this
reflex. Also, spinal reflexes are sudden in onset, whereas the pressor effect of
water ingestion is gradual. It is not know if this difference is explained by
gradual recruitment of afferent fibers activated by water ingestion, or if
unknown intermediate steps exist between water ingestion and afferent fiber
activation, or between efferent activation and the pressor effect.
Tank J, Schroeder C, Stoffels M, et al (2003) Pressor Effect of Water
Drinking in Tetraplegic Patients May Be a Spinal Reflex. Hypertension
41:1234-1239.
Autonomic Failure in Parkinson’s Disease. A Syndrome We Need to Learn More About
Autonomic failure can be seen in patients with otherwise
a classical presentation of Parkinson’s disease ("Parkinson’s plus"). Sharabi et
al evaluated 12 such patients. Mean orthostatic drop in systolic blood pressure
was 40 mmHg, suggesting that in some patients orthostatic hypotension was rather
modest by autonomic failure standards. Blood pressure response to Valsalva
maneuver was abnormal in all. As previously reported by this group of
investigators, all patients had decreased fluorodopamine cardiac uptake,
indicating loss of postganglionic sympathetic fibers. In this regard, autonomic
failure in Parkinson’s disease resembles that seen in pure autonomic failure,
which is also characterized by loss of post-ganglionic sympathetic fibers,
rather than that seen in multiple system atrophy. Patients with Parkinson’s plus
had a blunted increase in plasma norepinephrine on standing Unfortunately, only
relative changes but not actual plasma norepinephrine levels were reported. Of
interest, sweat production to iontophoretic administration of acetylcholine was
present in the forearm, indicating preserved sympathetic cholinergic fibers in
the forearm despite cardiac sympathetic denervation. Cholinergic parasympathetic
function was not reported. More detailed characterization of the autonomic
failure of Parkinson’s disease is needed, but these results suggest differential
involvement of autonomic pathways.
Autosomal recessive early-onset parkinsonism can result from
various mutations in the PARK2 (parkin, chromosome 6), PARK6 or PARK7
(chromosome 1) genes. Khan et al reported the clinical characteristics of 24
Parkinson’s patients with PARK2 mutations, including 11 isolated cases, and 13
patients from five unrelated families. Clinical characteristics were similar to
those previously reported for familial parkinsonism, but three new phenotypes
were observed: cervical dystonia, pure exercise-induced dystonia, and autonomic
dysfunction with peripheral neuropathy. Detailed autonomic function was not
systematically evaluated but "autonomic symptoms" were reported in 60% of
patients, including urgency (45%), impotence (38% of males) and orthostatic
faintness (13%). One case was evaluated in more detail and found to have
abnormal sympathetic and parasympathetic function, and asymptomatic axonal
peripheral neuropathy revealed by nerve conduction studies. More detailed
evaluation is required to determine if autonomic failure is indeed part of the
clinical presentation of genetic forms of Parkinson disorders, and to understand
its pathophysiology.
Sharabi Y, Li ST, Dendi R, et al (2003) Neurotransmitter specificity of
sympathetic denervation in Parkinson's disease. Neurology 60:1036-1039.
Khan NL, Graham E, Critchley P, et al (2003) Parkin disease: a phenotypic
study of a large case series. Brain 126:1279-1292.
Ganglionic Blockade and Blood Pressure
Variability in Hypertensive Disorders
The contribution of the sympathetic nervous system to
hypertension has long been suspected but difficult to assess. Diedrich et al
combined acute sympathetic withdrawal with ganglionic blockade with measurements
of cardiovascular variability, to study patients with multiple system atrophy (MSA,
characterized by sympathetically-driven supine hypertension), pure autonomic
failure (PAF, characterized by sympathetically-independent supine hypertension),
normal controls and patients with essential hypertension (HTN). Ganglionic
blockade with trimethaphan abolished high and low frequency heart rate
fluctuations and low frequency blood pressure variability (LFSBP).
"Intrinsic blood pressure" (after autonomic blockade) remained high in PAF but
dropped to normal in MSA. Baseline LFSBP was higher in MSA and HTN,
and very low in PAF. Of interest, patient groups that had high LFSBP
also had a higher LF/HFRRI ratio (a controversial index of "sympathovagal
balance") suggesting that this index is indeed influenced by sympathetic
function. Patients with HTN had a wider range of "intrinsic blood pressure" and
LFSBP levels. The decrease in LFSBP induced by ganglionic
blockade correlated with the reduction in blood pressure, with a steeper slope
in MSA and HTN compared to controls. Thus, ganglionic blockade, alone or coupled
to LFSBP, discriminated between human models of sympathetic-dependent
(MSA) and independent (PAF) hypertension. This approach may aid in assessing the
contribution of the sympathetic nervous system in essential hypertension, in
which sympathetic dependence is variably expressed.
Diedrich A, Jordan J, Tank J, et al (2003) The sympathetic
nervous system in hypertension: Assessment by blood pressure variability and
ganglionic blockade. J Hypertens 21:1677-1686.